PrEP: Postcode lottery of anti-HIV drug trial A game-changer in the fight against HIV, pre-exposure prophylaxis (PrEP) is a highly effective drug that reduces the risk of acquiring the condition. But as the NHS trials PrEP across England, many at high risk have struggled to get hold of the drug.
The Impact trial was launched in England in October 2017 with an initial 10,000 places at sexual health clinics for people at high risk of contracting HIV.
But there has been great demand for the drug, with sexual health charities inundated with stories of people being turned away due to a lack of places.
Responding to a request for comment for this article, NHS England said it was planning to fund 13,000 more places on the trial. BBC News
No comments:
Post a Comment